Board approves preferential issue of shares and warrants at Rs.336.60

Qip At PremiumFund Raising View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.3%Reaction day

₹374.00

prior close

₹380.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.0%+4.3% vs market

Pharmaceuticals peers, median of 173sector-0.7%+5.0% vs sector

On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 5.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

+0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.3+0.0+4.3-0.7+5.0

Next day

+5.4+1.3+4.1+0.6+4.8

+4.1+1.1+3.0+0.3+3.7

-0.7-1.7+1.0-2.3+1.6

-0.0-1.4+1.4-2.1+2.1

+1.9-0.6+2.5-2.5+4.4

+6.4+0.3+6.1-2.5+9.0

15d

+16.4-6.1+22.5-4.4+20.9

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Trident Lifeline board approved issuing 12,22,200 equity shares and up to 5,00,400 convertible warrants at Rs.336.60 each on preferential basis to 33 allottees. Equity value about Rs.41.14 crore, warrants up to Rs.16.84 crore. Promoter holding will dilute from 62.46% to 56.35%. EGM on Oct 27 for approval.

Likely market impact

Dilution for existing shareholders as promoter stake falls from 62% to 56%. Fresh equity raise of about Rs.58 crore.